Thanks, Madam Chair. It's nice to be here and see you all. Thank you to the witnesses. Thank you for sharing exciting research.
I am just filling in today, so I don't know the history. I know this is the first day of this study. I am going to ask about innovation more broadly, not just technical innovation.
Ms. Sabourin, in 2010 the FDA introduced plain language labelling for drug labels and monographs. Health Canada has been talking about introducing a similar policy since 2000. I am wondering when the agency will do so.